Inventor
MARTIN E. SANDERS
Inventor
US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides10%
C07CAcyclic or carbocyclic compounds8%
C12NMicroorganisms or enzymes6%
Y02ATechnologies for adaptation to climate change6%
C07BGeneral methods of organic chemistry4%
C07DHeterocyclic compounds4%
PatentTitleYear
12,383,521Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists202512,325,685RXR agonist salt form, polymorphs thereof, and uses thereof202512,115,193Methods of using RARg agonists for cancer treatment202411,998,521Use of an RXR agonist in treating drug resistant HER2+ cancers202411,919,848RXR agonist salt form, polymorphs thereof, and uses thereof202411,896,558Use of an RXR agonist and taxanes in treating Her2+ cancers202411,793,835Methods of using RARg agonists for cancer treatment202311,786,555RAR selective agonists in combination with immune modulators for cancer immunotherapy202311,779,558Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy202311,737,996Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy202311,690,832Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones202311,690,831Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones202311,648,223Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy202311,517,549Treatment of disease with esters of selective RXR agonists202211,224,583Use of an RXR agonist in treating HER2+ cancers2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to IO THERAPEUTICS INC (15)· patent assignee history
2022–2024Patents assigned to UNIV TEXAS (3)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to IO THERAPEUTICS (1)· patent assignee history
2025Patents assigned to DARTMOUTH COLLEGE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IO THERAPEUTICS INC | 15 | 2022–2025 |
| UNIV TEXAS | 3 | 2022–2024 |
| DARTMOUTH COLLEGE | 1 | 2025 |
| IO THERAPEUTICS | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 15 | 2022–2025 |